Skip to main content
GRI logo

GRI Bio, Inc.

GRINASDAQHealthcareBiotechnology

$1.40Today:- (-)1Y −28.21%

As of Oct 15, 2026 close

Market cap
$2.53M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.36$64.12
Volume (live)
-
Avg. volume (3M)
402.91K

GRI Bio (GRI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), GRI Bio used $10.19M of cash in operating activities and spent $3.00K on capital expenditures. That left free cash flow of −$10.19M. It repurchased $1.00K of its own shares.

GRI Bio Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for GRI Bio, Inc. (GRI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-11.96-8.21-13.04-13.04-3.22-9.30-4.82-3.46-4.31
Depreciation & Amortization0.000.000.000.000.000.070.080.000.00
Stock Based Compensation0.790.150.390.390.030.000.000.000.00
Change in Working Capital0.93-0.451.681.681.520.220.890.160.46
Change in Accounts Payable0.66-0.392.162.160.90-0.310.98-0.040.29
Change in Other Working Capital0.05-0.11-0.48-0.600.620.53-0.090.200.17
Other Operating Activities0.05-0.111.981.980.590.700.150.421.48
Net Cash from Operating Activities-10.19-8.61-8.99-8.99-1.09-8.31-3.71-2.88-2.37
Investing Activities
Capital Expenditures0.00-0.40-0.01-0.010.000.000.000.000.00
Purchases of Investments0.000.000.00-0.00-3.840.000.000.00
Other Investing Activities0.000.400.00-0.000.000.000.000.00
Net Cash from Investing Activities0.000.00-0.01-0.010.00-3.840.000.000.00
Financing Activities
Debt Repayment0.000.001.25-0.201.250.240.001.110.00
Common Stock Issued15.5613.1012.2512.260.0015.500.004.982.99
Common Stock Repurchased0.000.000.00--0.120.000.000.000.00
Other Financing Activities-2.17-2.03-2.70-2.71-0.120.000.000.000.00
Net Cash from Financing Activities13.3911.8310.8010.801.0115.750.006.092.99
Summary
Effect of Forex Changes on Cash0.000.000.00-0.000.000.000.000.00
Net Change in Cash3.203.221.801.80-0.083.59-3.713.210.61
Cash at Beginning of Period5.031.810.010.010.090.113.820.610.00
Cash at End of Period8.235.031.811.810.013.700.113.820.61
Free Cash Flow-10.19-8.61-9.00-9.00-1.09-8.31-3.71-2.88-2.37
Supplemental Disclosures
Interest Paid----0.03----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About GRI Bio Cash Flow

What is GRI Bio's free cash flow?

GRI Bio had negative free cash flow of $10.19M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$10.19M minus $3.00K of capital expenditures.

How much does GRI Bio spend on capital expenditures?

GRI Bio spent $3.00K on capital expenditures in fiscal 2025, compared with $396.00K a year earlier.

Does GRI Bio pay dividends or buy back shares?

Yes. In fiscal 2025 GRI Bio returned $1.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition